皓宸医疗(002622) - 2020 Q3 - 季度财报

Financial Performance - Operating revenue for the reporting period was CNY 28,585,157.25, a decrease of 3.25% year-on-year, while year-to-date revenue was CNY 58,217,553.26, down 40.09%[7] - Net profit attributable to shareholders of the listed company was CNY 4,708,167.83, an increase of 2,085.82% year-on-year, but year-to-date net profit was CNY -27,711,292.48, down 91.28%[7] - Basic earnings per share for the reporting period were CNY 0.0056, an increase of 1,766.67% year-on-year, while year-to-date earnings per share were CNY -0.0330, down 91.80%[7] - Total revenue for the period was CNY 58,217,553.26, a decrease of 40.17% compared to CNY 97,172,107.69 in the previous period[55] - Net profit for the period was CNY -27,711,292.48, compared to CNY -14,442,647.78 in the previous period, indicating a worsening loss[57] - The total comprehensive income for the period was CNY 4,166,131.84, compared to CNY -2,140,143.55 in the previous period[54] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,734,236,335.04, a decrease of 1.81% compared to the end of the previous year[7] - The total current assets decreased to CNY 427,014,637.15 from CNY 492,324,057.80, indicating a decline of about 13.3%[39] - The total liabilities decreased to CNY 477,195,110.53 from CNY 482,178,870.59, indicating a decline of approximately 1.6%[41] - The total owner's equity remained stable at ¥840,000,000.00, unchanged from the previous period[41] - The total liabilities amounted to CNY 482,178,870.59, with total equity at CNY 1,284,021,737.93, resulting in total assets of CNY 1,766,200,608.52[73] Cash Flow - Net cash flow from operating activities was CNY 20,328,615.23, an increase of 542.04% year-on-year, with year-to-date cash flow at CNY 32,107,785.48, up 289.33%[7] - The net cash flow from operating activities is 32,107,785.48, a significant improvement from -16,958,299.70 in the previous period[64] - The total operating cash inflow is 107,364,752.48, down from 130,760,093.67 in the previous period[64] - The total operating cash outflow is 75,256,967.00, compared to 147,718,393.37 in the previous period, indicating a reduction in cash outflows[64] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 49,900[11] - The largest shareholder, Guangzhou Huiyin Rifen Investment Partnership, holds 23.81% of the shares, totaling 200,000,000 shares[11] Expenses and Income - The management expenses decreased by CNY 39.53 million, a 58.77% decrease compared to the same period last year, due to reduced expenses following the disposal of subsidiaries and enhanced cost control[17] - The tax expenses decreased by CNY 3.34 million, a 99.50% decrease compared to the same period last year, due to reduced income following the disposal of subsidiaries[18] - Financial expenses for the period were CNY 30,626,655.41, an increase from CNY 27,659,939.53 in the previous period[57] Investment and Other Income - Government subsidies recognized in the current period amounted to CNY 3,275,351.40, which are closely related to the company's business operations[8] - The company reported an investment income of CNY 12,835,346.84, up from CNY 11,320,331.56, showcasing improved returns on investments[48] - Investment income for the period was CNY 43,430,179.18, up from CNY 39,817,699.28 in the previous period[57] Changes in Equity - The total equity attributable to shareholders increased to CNY 1,149,486,049.34 from CNY 1,106,504,145.34, reflecting a positive shift in shareholder value[45] - The total owner's equity attributable to the parent company is CNY 1,284,022,263.97[73] Other Financial Metrics - The weighted average return on net assets was 0.38%, a slight increase of 0.36% compared to the previous year[7] - The company's long-term equity investments rose to ¥600,829,691.43 from ¥557,232,726.34, reflecting an increase of approximately 7.8%[40] - The company's cash and cash equivalents increased to ¥104,013,219.50 as of September 30, 2020, compared to ¥75,031,573.53 at the end of 2019, representing a growth of approximately 38.7%[39]